Novartis India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
1,609.70
-25.2 (-1.54%)
BSENSE

Aug 06, 03:30 PM

BSE+NSE Vol: 29.0 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Novartis India
IOL Chemicals
Innova Captab
Bliss GVS Pharma
Morepen Labs.
Gufic BioScience
RPG LifeScience.
Advanced Enzyme
Aarti Drugs
Guj. Themis Bio.
Zota Health Care

Why is Novartis India Ltd ?

1
The company is Net-Debt Free
2
Healthy long term growth as Operating profit has grown by an annual rate 40.23%
3
The company has declared positive results in Jun'2026 after 2 consecutive negative quarters
  • CASH AND CASH EQUIVALENTS(HY) Highest at Rs 667.70 cr
  • DEBTORS TURNOVER RATIO(HY) Highest at 9.56 times
  • NET SALES(Q) Highest at Rs 103.81 cr
4
Increasing Participation by Institutional Investors
  • Institutional investors have increased their stake by 0.81% over the previous quarter and collectively hold 1.52% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Novartis India should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-0.86%
EBIT Growth (5y)
40.23%
EBIT to Interest (avg)
54.25
Debt to EBITDA (avg)
0.42
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
0.48
Tax Ratio
27.90%
Dividend Payout Ratio
61.15%
Pledged Shares
0
Institutional Holding
1.52%
ROCE (avg)
36.34%
ROE (avg)
11.13%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
40
Industry P/E
37
Price to Book Value
4.83
EV to EBIT
32.86
EV to EBITDA
32.26
EV to Capital Employed
21.41
EV to Sales
8.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
60.10%
ROE (Latest)
11.95%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 667.70 cr

DEBTORS TURNOVER RATIO(HY)

Highest at 9.56 times

NET SALES(Q)

Highest at Rs 103.81 cr

PBDIT(Q)

Highest at Rs 34.91 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 33.63%

PBT LESS OI(Q)

At Rs 34.43 cr has Grown at 29.39%

PAT(Q)

Highest at Rs 32.21 cr.

EPS(Q)

Highest at Rs 13.05

-3What is not working for the Company
ROCE(HY)

Lowest at 15.95%

Loading Valuation Snapshot...

Here's what is working for Novartis India

Net Sales - Quarterly
Highest at Rs 103.81 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 34.91 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 33.63%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 34.43 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 34.43 cr has Grown at 29.39%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 32.21 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 13.05
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Cash and Cash Equivalents - Half Yearly
Highest at Rs 667.70 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Highest at 9.56 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio